Elanco Animal Health Incorporated ELAN

Company Overview

Elanco Animal Health Incorporated is a global animal health company that develops, manufactures, and markets products to prevent and treat disease in animals, improve animal well-being, and enhance productivity in livestock. The company operates within the animal health and veterinary pharmaceutical industries, serving both companion animal and food-producing animal markets. Elanco’s primary revenue drivers are veterinary therapeutics, vaccines, parasiticides, and nutritional products sold to veterinarians, livestock producers, and distributors.

The company operates through two principal business segments: Pet Health and Farm Animal. Elanco serves veterinarians, pet owners, livestock producers, and integrated food companies, with a strategic focus on science-based innovation and established product brands. Elanco traces its origins to 1954 as part of Eli Lilly and Company and was spun off as an independent publicly traded company in 2018, subsequently expanding its scale and portfolio through acquisitions, most notably the integration of Bayer’s animal health business.